Cargando…
Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study
AIM: Patients with severe mitral regurgitation (MR) and acute heart failure (HF) have refractory symptoms without adequate response to medical therapy. The objective of this analysis was to assess the impact of the MitraClip device in acutely ill HF patients, characterized by NYHA Class IV at baseli...
Autores principales: | Shuvy, Mony, von Bardeleben, Ralph Stephan, Grasso, Carmelo, Raake, Philip, Lurz, Philipp, Zamorano, Jose L., Asch, Federico, Kar, Saibal, Maisano, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053175/ https://www.ncbi.nlm.nih.gov/pubmed/36599332 http://dx.doi.org/10.1002/ehf2.14273 |
Ejemplares similares
-
Percutaneous treatment of mitral regurgitation with MitraClip device
por: Pregowski, Jerzy, et al.
Publicado: (2013) -
Managing mitral regurgitation: focus on the MitraClip device
por: Magruder, J Trent, et al.
Publicado: (2016) -
Considerations on the use of MitraClip in the treatment of mitral regurgitation
por: Musumeci, Giuseppe, et al.
Publicado: (2020) -
Critical evaluation of the MitraClip system in the management of mitral regurgitation
por: Deuschl, Florian, et al.
Publicado: (2016) -
Re‐do MitraClip in patients with functional mitral valve regurgitation and advanced heart failure
por: Kreusser, Michael M., et al.
Publicado: (2021)